Drugs News and Research

RSS

Study reveals self-harm is leading cause of pregnancy-related deaths in Colorado

Self-harm was the leading cause of pregnancy-associated deaths in Colorado from 2004 to 2014, ahead of car crashes, medical conditions and homicide, according to researchers at the University of Colorado Anschutz Medical Campus.

9 Dec 2016

Studies show how overactive immune response may contribute to heart disease in psoriasis patients

Psoriasis is well-known for causing too many skin cells on elbows, knees, and across the body, but people living with psoriasis may also be at an increased risk of heart disease.

9 Dec 2016

New model can simplify process of mixing perfect drug cocktails

Drug cocktails, such as those for treating cancer, are best when the proper ingredients are mixed in the right proportions - just like the alcoholic versions offered at the local bar.

9 Dec 2016

Resilience lowers risk for developing alcohol use disorders, study shows

Resilience considerably reduces risk for developing alcohol use disorders, according to a new study conducted by researchers at Virginia Commonwealth University and Lund University in Sweden.

8 Dec 2016

Duke researchers develop new cell-based drug screening test for dystonia

Duke University researchers have identified a common mechanism underlying separate forms of dystonia, a family of brain disorders that cause involuntary, debilitating and often painful movements, including twists and turns of different parts of the body.

8 Dec 2016

Woman’s history of drug use can help predict risk of postpartum stress and anxiety

New research from North Carolina State University and the University of British Columbia finds that a woman's lifetime history of drug use can help predict whether the woman will suffer from problems with stress and anxiety after childbirth.

8 Dec 2016

Pioneering research in caves provides new insights into origins of antibiotic resistance

Pioneering work being carried out in a cave in New Mexico by researchers at McMaster University and The University of Akron, Ohio, is changing the understanding of how antibiotic resistance may have emerged and how doctors can combat it in the future.

8 Dec 2016

AstraZeneca introduces world’s most advanced drug discovery robot

AstraZeneca entered a new era in drug development today by unveiling NiCoLA-B, the world’s most advanced drug discovery robot, capable of performing experiments at an industrial scale in the search for new, life-saving medicines.

8 Dec 2016

Research shows alternative strategy to administer antibody-based immunotherapy for bladder cancer

Antibody-based immunotherapy is a new promising method to treat cancer. Unfortunately, today's treatments can result in adverse side effects.

8 Dec 2016

High levels of copeptin could increase risk of kidney, heart disease in Type 1 diabetes patients

Type 1 diabetes patients with elevated albumin in their urine had three times the risk of life-threatening kidney and cardiac disease as those with normal levels, according to researchers at the University of Colorado Anschutz Medical Campus.

8 Dec 2016

Researchers discover biological pathway that plays vital role in tumor development

An international team led by researchers from the Technion-Israel Institute of Technology's Rappaport Faculty of Medicine and the Technion Integrated Cancer Center has discovered a biological pathway that plays an important role in tumor development.

7 Dec 2016

Brain metastasis persists in women with HER2-positive breast cancer despite new targeted therapies

While new targeted treatments developed across the past two decades have led to dramatic survival improvements for women with HER2-positive metastatic breast cancer, University of North Carolina Lineberger Comprehensive Cancer Center researchers and collaborators report that rates of breast cancer brain metastasis for women with this disease have not substantially declined.

7 Dec 2016

Scientists uncover new class of compounds that could help target cancer cells

Scientists from Trinity College Dublin have uncovered a new class of compounds - glyconaphthalimides - that can be used to target cancer cells with greater specificity than current options allow.

7 Dec 2016

TSRI scientists identify potential therapeutic target for age- or Alzheimer's disease-related memory deficits

Scientists from the Florida campus of The Scripps Research Institute have made an important discovery toward the development of drugs to treat age-related memory loss in diseases like Alzheimer's.

7 Dec 2016

Alkaloid in ayahuasca beverage triggers neurogenesis in human neural cells

Ayahuasca is a beverage that has been used for centuries by Native South-Americans. Studies suggest that it exhibits anxiolytic and antidepressant effects in humans.

7 Dec 2016

Brazilian researchers propose new way for treating thalassemia major

Iron accumulation in myocardial cells, potentially resulting in heart failure or fatal arrhythmia, is one of the complications most feared by patients with thalassemia major, a hereditary disease also known as Mediterranean anemia.

7 Dec 2016

New SFU research could revolutionize IVF success rates

Over the past three years, Canadian women desperate to conceive a child endured more than 82,000 attempts to become impregnated using in vitro fertilization (IVF), a reproductive technique that fertilizes a woman's eggs outside of her body.

7 Dec 2016

New research reveals role of two genetic mutations in subset of acute myeloid leukemia

Two genetic mutations known to play a role in many solid cancers might also help explain why a subset of acute myeloid leukemia (AML) patients develop the disease, according to new research from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

7 Dec 2016

FDA announces important steps to improve consumer access to hearing aids

The U.S. Food and Drug Administration today announced important steps to better support consumer access to hearing aids.

7 Dec 2016

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

A common class of drugs for vision loss may actually add to the problem in some patients, according to new research co-led by scientists at The Scripps Research Institute (TSRI).

7 Dec 2016

Drugs News and Research

Study reveals self-harm is leading cause of pregnancy-related deaths in Colorado

Studies show how overactive immune response may contribute to heart disease in psoriasis patients

New model can simplify process of mixing perfect drug cocktails

Resilience lowers risk for developing alcohol use disorders, study shows

Duke researchers develop new cell-based drug screening test for dystonia

Woman’s history of drug use can help predict risk of postpartum stress and anxiety

Pioneering research in caves provides new insights into origins of antibiotic resistance

AstraZeneca introduces world’s most advanced drug discovery robot

Research shows alternative strategy to administer antibody-based immunotherapy for bladder cancer

High levels of copeptin could increase risk of kidney, heart disease in Type 1 diabetes patients

Researchers discover biological pathway that plays vital role in tumor development

Brain metastasis persists in women with HER2-positive breast cancer despite new targeted therapies

Scientists uncover new class of compounds that could help target cancer cells

TSRI scientists identify potential therapeutic target for age- or Alzheimer's disease-related memory deficits

Alkaloid in ayahuasca beverage triggers neurogenesis in human neural cells

Brazilian researchers propose new way for treating thalassemia major

New SFU research could revolutionize IVF success rates

New research reveals role of two genetic mutations in subset of acute myeloid leukemia

FDA announces important steps to improve consumer access to hearing aids

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News